Control of beta-cell function by PHIP: Implications for Type I and II Diabetes Laboratory Medicine...
-
Author
kelley-banks -
Category
Documents
-
view
218 -
download
0
Embed Size (px)
Transcript of Control of beta-cell function by PHIP: Implications for Type I and II Diabetes Laboratory Medicine...

Control of beta-cell function by PHIP: Implications for Type I and
II Diabetes
Laboratory Medicine and PathobiologyFaculty of Medicine
University of Toronto

IGF-1 Signaling Pathways Play Crucial Role in Pancreatic β-cell Function
β-Cell
PH

Introduction
PH PTB
NPXpY?
Receptor interaction
1 1243
IR
IRS1pY
pYpY
pY
SHP-2NCK
GRB2PI3K
IRS-1 PH
1 902 aa
PBR 150
PHIP
•PHIP (Pleckstrin Homology domain Interacting Protein) was originally identified as a 902 amino acid protein that interacts with the PH domain of insulin receptor substrate 1 (IRS1)
•PHIP was shown to regulate insulin-dependent mitogenic and metabolic responses in skeletal muscle cells (Farhang-Fallah J, et al. MCB 2002)

Objective 1
Given the apparent role of PHIP in IRS signaling pathways and the importance of IRS proteins in proliferation and survival in β-cells we sought to investigate the functional role of PHIP in β-cells

Q: Is PHIP expressed in beta-cells?

PHIP is Highly Expressed In Mouse Islets(QPCR)
Rel
ativ
e P
HIP
mR
NA
exp
ress
ion
MIN6Isl
ets
Acinar
Who
le
WAT
Brain
Pancreas
7.3 Fold
10.0
0.2
0.4
0.6
0.8
1.0
Muscle

Min6 INS-1
a-PHIP
DAPI
PHIP Is Localized to Nuclei of Insulinoma Cell Lines (IHC)

PHIP Predominantly Expressed in Nuclei of Islet Cells (IHC)
a-PHIP a-Insulin a-PDX1
DAPI a-Glucagon H&E
x100
x100
x200
a-PHIP
DAPI

PHIP Structure
•WD40 domains - protein-protein interaction modules implicated in transcriptional regulation, vesicular formation and trafficking and control of various aspects of cell division.
•BromoDomains - found predominantly in proteins that regulate chromatin remodeling such as nuclear histone acetyltransferases and transcriptional coactivators
1821 a.a (206kDa)
1821 a.a (206kDa)
1498 a.a (165kDa)
1266 a.a (143kDa)
902 a.a (105kDa)
BD
isoform 9

Q: What isoform of PHIP1 predominantly expressed in beta-
cells?

PHIP1 – a 206 kDa PHIP Isoform is Predominant Species in Mouse Islets and Insulinoma Cell Lines
ISLETS
INS1
MIN
6
230 -
95 -
a-PHIP 130 -
206 kDa
230 -
95 -
130 -
PHIP1
PHIP
Cont.
Short Isoform
Long Isoform
Transfection
a-PHIP
Western Blotting

Q: Does overexpression of PHIP1 influence the growth of pancreatic β-cells ?

24 48 72 96
100
200
300
400
500
600
700
800
Adenoviral-mediated Expression of PHIP1 Enhances Proliferation in INS-1 cells (MTT Assay)
Hours after Infection
Nu
mb
er
of
Via
ble
Ce
lls(O
D45
0)
(10%FBS)
*
IRS2PHIP1GFP

Q: Does PHIP1 over expression influence the IGF-1 dependent growth of β-cells ?

10.0
0.5
1.0
1.5
2.0
2.5
3.0
Adenoviral-mediated overexpression of PHIP1 enhances IGF1-dependent mitogenesis in INS-1 Cells (BRDU Assay)
BR
DU
In
corp
ora
tio
n(F
old
Ch
ang
es)
IGF-1 - + - + - +
AdGFP AdPHIP1 AdIRS210nM
1.8 Fold
1.3 Fold

Q: What possible mechanisms mediate increase in proliferation rate of PHIP1
overexpressing cells ?

Ad-mediated Overexpression of PHIP1 Promotes IGF1-Dependent Increase of Cyclin D2 Expression in INS-1 cells
Cyclin D2-
Cyclin D1-
Actin-
Western Blotting
IGF-1 - + - + - +
AdGFP AdPHIP1 AdIRS2
Luciferase Assay
IGF-1 - + - + AdGFP AdPHIP1
0.5 0.6 0.7 0.8 0.9 1.00.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
2.1 Fold
2.5 Fold
Cyclin D2 promoter Luc
Lu
cife
rase
Un
its
(Fo
ld C
ha
ng
es
)
Cyclin D2reporter

Q: Does PHIP1 is necessary component of IGF-1 and IRS2 signaling pathways leading to
mitogenic responses?

siRNA-mediated Knockdown of PHIP1 Blocks IGF-1 and IRS2-induced Mitogenesis and Expression of Cyclin D2, but
not AKT phosphorylation.
H3 -
Th
ymid
ine
Inco
rpo
rati
on
(Fo
ld C
han
ges
)
ScrGFP
SiPHIPGFP
ScrIRS2
siPHIPIRS2
*
- + - + - + - +IGF-1 (10nM)
- + - + - + - +IGF-1 (10nM)
PHIP1-
IRS2-
Cyclin D2-
H3Thymidine Incorporation Assay
Western Blotting
ScrGFP
SiPHIPGFP
ScrIRS2
siPHIPIRS2
pSer473AKT-
*

Summary of PHIP Role in β-cell Proliferation:
• Long Isoform of PHIP – PHIP1 is predominantly expressed in nuclei of β-cells
• PHIP1 promotes proliferation and potentiates IGF1-stimulated mitogenesis in β-cells
• PHIP1 drives transcriptional induction of Cyclin D2 promoter
• PHIP1 expression is essential for IGF1 and IRS2-induced β-cell replication

Q: Does PHIP1 plays any role in β-cell apoptosis?

•Chronic elevation of free fatty acids (FFAs) leads to the generation of reactive oxygen species, inhibition of insulin biosynthesis and induction of pancreatic -cell apoptosis both in vivo and in vitro (β-cell lipotoxicity)
•Inflammatory cytokines such as TNF-α , IL-1ß, and Interferon-γ are cytotoxic to ß-cells and may contribute to ß-cell death in obesity which has been described as a state of low-level chronic inflammation
•TNF-α , IL-1ß, and Interferon-γ are major mediators of β-cell apoptosis in Type 1 diabetes
•Increased IRS2 expression or exposure to IGF1 inhibits FFA and cytokine-induced apoptosis in β-cells
Role of β-cell apoptosis in diabetes

To evaluate the effect of PHIP1 overexpression on FFA-induced apoptosis
Objective 2

- IGF1 + IGF1
Adenoviral-mediated Overexpression of PHIP1 Inhibits FFA-induced INS-1 Cell Apoptosis
2.6
4.1

Q: What molecular mechanisms could mediate the inhibitory effect of PHIP1 overexpression on FFA-induced apoptosis?
• Prevent AKT translocation to membrane
• Activation of PP2A
• Increased Ser/Thr Phosphorylation of IRS2 by activated PKC

10.0
0.5
1.0
1.5
2.0
pS
er47
3A
kt
/AK
T r
ati
o
GFPBSA
GFPOA
PHIP1 OA
IRS2OA
Akt-
pSer473 AKT-
IRS2-
PHIP-
IGF-1 (10ng/ml)
Casp9-(cleaved)
Adenoviral-mediated Expression of PHIP1 Induces Activation of pAKT and Inhibition of pro-Caspase-9 and -3 Cleavage
Casp3-(cleaved)
GFPBSA
IGF-1
GFP OA
PHIP1OA
IRS2OA
- -+ + - -+ +
- + - + - + - +
10.0
0.5
1.0
1.5
2.0
Ca
sp
as
e9
/A
cti
n C
as
pa
se
3 /
Ac
tin
8.6 fold
1.75 fold
2.7 folds
*
*
5.8 Folds

Apoptosis
Apoptosis
Q: Does AKT activation is crucial for PHIP1 antiapoptotic effect ?
•KD-AKT -“Kinase Dead” AKT due to mutation in ATP-binding site
Apoptosis

Overexpression of “kinase-dead” AKT Blocks Protective Effect of PHIP1 on FFA-induced apoptosis
•AKT plays crucial role in antiapoptotic effect of PHIP1

Q: How does PHIP1 increase activity of AKT?
PHIP1
?
PHIP1
?
?
?
??

•PHIP1 and IRS2 have different subcellular localization in β-cells
IF (Min6)
Anti-PHIP Anti-IRS2
DAPI DAPI
PHIP1 role in regulation AKT signalling
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1 2
PTE
N m
RN
A
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
1 2
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
1 2
SH
IP2 m
RN
Am
TO
R m
RN
A
•The precise mechanism by which PHIP1 converge on AKT signaling is still not clear
AdGFP
qPCR(INS1)
AdPHIP1

Summary on PHIP role in FFA-induced apoptosis:
•PHIP1 overexpression protects INS1 cells against FFA induced apoptosis in vitro
•Ectopic PHIP1 overexpression induces AKT phosphorylation and inhibits Caspase-9 and -3 activation
•AKT has essential role in the PHIP1 signaling pathway that promotes beta-cell survival
Q: Will PHIP1 exhibit similar effect on β-cells in vivo model of Type 2 Diabetes?

Rodent High Fat Diet (HFD) induced Experimental Diabetes as a Model of Type 2 Diabetes
•Prolonged (>3 months) HFD in C57BL/6J background mice results in overt diabetes (Mills E, et al., Am.J.Physiol, 1993)
Compensatory β-cell hyper-
plasia
Diabetes
HyperlipidemiaObesity
Increased PeripheralResistance to Insulin
Hyperinsulinemia
Failure of β -cells to adapt to
changes in metabolic demand
High Fat Diet 3-5 months
•Overexpression of IRS2, AKT, PDX1, Glucokinase and CA-STAT5 in β-cells blocks or alleviates development of HFD-induced Diabetes

Generation and Charachterization of Tg-PHIP1 mice
PHIP1 HA
DAPI DAPI
x200
WB from extracted Islets
RIP HA PHIP1
RIP-HA-PHIP1 construct
IHC
WT TG1 TG2 TG3

Body Weight and Fed Blood Glucose Levels in Wild Type (WT) or TG-PHIP Mice after 20 weeks on Standard or High Fat Diet
10
5
10
15
20
25
30
35
40
45
50
B
ody
Wei
ght,
g (
M+
SE
M)
WT (n=19-25) TG-PHIP (n=14-18)
10,2%
10
2
4
6
8
10
12
14
25%
Fed
Blo
od
Glu
cose
, mM
(M
+S
EM
)
Day 0 20weeksNormalChow
20weeksHFDiet
Day 0 20weeksNormalChow
20weeksHFDiet
43%27%

0 20 40 60 80 100 12002468
101214161820222426283032
0 20 40 60 80 100 12002468
101214161820222426283032
0 20 40 60 80 100 12002468
101214161820222426283032
0 20 40 60 80 100 12002468
10121416182022242628303234
TG-PHIP Mice Have Improved Glucose Tolerance After 12 and 20 Weeks on High Fat Diet (GTTest)
Blo
od
Glu
co
se
mM
(M
+S
EM
)
Blo
od
Glu
co
se
mM
(M
+S
EM
)
Blo
od
Glu
co
se
mM
(M
+S
EM
)
Blo
od
Glu
co
se
mM
(M
+S
EM
)
*
*
* *
*
(Min) (Min)
(Min) (Min)
Normal Chow 12 Weeks
Normal Chow 20 Weeks
HF Diet 12 Weeks
HF Diet 20 Weeks
WT (n=10-17) TG-PHIP (n=10-12) IP Glucose Injection 2g/kg

Q: How does PHIP1 overexpression improve glucose tolerance?

Ins
uli
n (
ng
/ml*
min
/Ce
lls
DN
A)
Ins
uli
n (
ng
/ml/
min
/50
is
lets
)
16.7mM Glucose
GLP1
Phase I Phase I
16.7mM Glucose
GLP1
Phase I Phase I
TG-PHIP Mice Have Improved Glucose Stimulated Insulin Secretion (Perfusion Assay) After 20 Weeks on HFD
Q: Is Insulin secretion from TG-PHIP islets higher due to increased number of β-cells per islet?
WT (n=3) TG-PHIP (n=3)

10
1
2
3
4
5
6
7
8
9
10
11
10.000
0.002
0.004
0.006
0.008
0.010
0.012
0.014
0.016
0.018
0.020
*In
sulin
Co
nte
nt
(ng
/ml/m
in/ 5
0 is
lets
)
Insu
lin C
on
ten
t(n
g/m
l*m
in/ D
NA
Co
nte
nt)
INS
ULIN
WT TG-PHIP WT TG-PHIP
TG-PHIP mice islets Wild Type mice islets
Tg-PHIP Mice Islets Have Increased Number of β-cells

Summary on PHIP role in HFD-induced Diabetes:
•Transgenic mice selectively overexpressing PHIP1 in β-cells have decreased incidence of HFD induced diabetes
•Protective effect of PHIP1 on HFD induced Diabetes mediated via increase of β-cell proliferation or inhibition of apoptosis

Objective 3
To evaluate role of PHIP1 in cytokine-induced β-cell apoptosis

A Model of Signaling Pathways Involved in β-cell Cytokine-induced Apoptosis
β-Cell

Q: Does PHIP1 overexpression inhibit cytokine-induced β-cell apoptosis?

Adenoviral-mediated PHIP1 over expression inhibits cytokine-induced (IL-1β+IFNγ) apoptosis in INS1 cells
10.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
2.2
2.5 fold
Cont PHIP1
Cytokines(24hrs)
- + - +
Ap
op
tosi
s(f
old
ch
ang
es)
Cont PHIP1
- + - +Cytokines(24hrs)
PHIP1-
Caspase3-
Tubulin-
MDM2-
PSerAKT-
Cytokines mix:Interferon-γ 50ng/mlIL-1β 10ng/ml

WT +cytokine mix
TG-PHIP +cytokine mix
INS
UL
IN
TU
NE
LD
AP
I
PHIP1 Inhibits Induction of Cytokine-induced Apoptosis in Dispersed Islets of RIP7-PHIP1 mice (48hrs exposure; TUNEL assay)
102468
1012141618202224262830323436
WildType
Tg-PHIP1
Cytokines(24hrs)
- + - +
3.7 fold
Mer
ge
INS
UL
INM
erg
e
TU
NE
LD
AP
I
% o
f T
UN
EL
po
siti
ve β
-cel
ls

Q: Does PHIP1 knockdown enhances cytokine-induced apoptosis?

siRNAi-mediated PHIP1 Knockdown Enhances Cytokine-induced Apoptosis in INS1 Cells
10
2
4
6
8
10
12
Ap
op
tosi
s(f
old
ch
ang
es)
Cont siPHIP1
Cytokines(24hrs)
- + - +
3.1 fold
Cytokines(24hrs)
PHIP1-
Caspase3-
Tubulin-
MDM2-
PSerAKT-
Cont siPHIP1
- + - +

0 4 8 12 16 20 24 2802468
1012141618202224262830
0 4 8 12 16 20 24 2805
10152025303540455055
PHIP1 Enhances Cytokine-induced Expression of STAT-dependent Antiapoptotic Genes IRF1, SOCS1 and SOCS3
(qPCR)R
ela
tive m
RN
A level
* *
*STAT1 IRF1
0 4 8 12 16 20 24 280
5
10
15
20
25
30
35
0 4 8 12 16 20 24 280.0
0.5
1.0
1.5
2.0
2.5
3.0
Rela
tive m
RN
A level
Rela
tive m
RN
A level
Rela
tive m
RN
A level
Cytokine Mix Cytokine Mix
*
*
*
*
*SOCS1 SOCS3
AdPHIP1
AdGFP
AdPHIP1
AdGFP
hrs. hrs.

1. We have identified a novel WD40 repeat-containing isoform of PHIP which expressing predominantly in the nuclei of beta-cells.
2. Overexpression of PHIP1 in β-cells results in enhanced levels of proliferation and decreased apoptosis.
3. The PHIP signaling network seems to regulate survival and apoptosis through a variety of intracellular mediators such as caspases, D-type cyclins, PKB and STAT1/SOCS1 signaling.
4. PHIP1 appears to be a new physiological regulator of IRS2 and STAT signaling in pancreatic -cells. This implies that a critical expression level of PHIP1 is required for general β-cell survival.
5.Approaches that promote PHIP1 expression in β-cells could provide important treatments for β-cell failure and diabetes.
Summary of Our Study

Acknowledgements
Collaborators:
Dr. Michael B. WheelerDr. Adria Giacca
Dr. H. Gaisano
Special Thanks to BBDC for providing financial support of this study